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Background: Industry sponsorship has been identified as a factor correlating with positive research findings in
several fields of medical science. To date, the influence of industry sponsorship in general and abdominal surgery
has not been fully studied. This protocol describes the rationale and planned conduct of a systematic review to
determine the association between industry sponsorship and positive outcome in randomised controlled trials in
general and abdominal surgery.
Methods/design: A literature search in the Cochrane Library, MEDLINE and EMBASE and additional hand searches
in relevant citations will be conducted. In order to cover all relevant areas of general and abdominal surgery, a new
literature search strategy called multi-PICO search strategy (MPSS) has been developed. No language restriction will
be applied. The search will be limited to publications between January 1985 and July 2014. Information on funding
source, outcome, study characteristics and methodological quality will be extracted.
The association between industry sponsorship and positive outcome will be tested by a chi-squared test. A
multivariate logistic regression analysis will be performed to control for possible confounders, such as number of
study centres, multinational trials, methodological quality, journal impact factor and sample size.
Discussion: This study was designed to clarify whether industry-sponsored trials report more positive outcomes
than non-industry trials. It will be the first study to evaluate this topic in general and abdominal surgery. The
findings of this study will enable surgical societies, in particular, to give advice about cooperation with the industry
and disclosure of funding source based on empirical evidence.
Systematic review registration: PROSPERO CRD42014010802
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The debate about the presence and extent of inappropriate
industry influence on medical professionals began in the
1980s [1,2]. Shortly thereafter, a positive association be-
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unless otherwise stated.was first shown for pharmaceutical clinical trials [3]. This
topic, referred to as industry bias, has meanwhile been
studied in many different medical disciplines, and in 2012,
a Cochrane review showed a relative risk of 1.32 (95%
confidence interval 1.21–1.44) for industry-funded studies
to report a positive outcome in a meta-analysis of 48
primary studies. One possible explanation for this differ-
ence between industry-funded trials and those with inde-
pendent funding was found to be conclusions not justified
by the study data. Other quality characteristics, such as
risk of bias, did not differ between the two groups [4].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lished on the potential effect of industry sponsorship in
various surgical disciplines. Five of these studies demon-
strated a significant association of industry sponsorship
and positive research outcome [6-8,12,13], and six studies
did not show an association [5,9-11,14,15] (Table 1). Only
two, Lubowitz et al. for orthopaedic surgery and Sun et al.
for surgery in otorhinolaryngology (ORL), searched trials
systematically [9,14]. The remaining nine studies selected
their samples from one or more arbitrarily defined and
mostly high-impact journals. This non-systematic ap-
proach represents the principal methodological limitation
of existing studies into the effect of industry funding, as
the sample might not be representative for the whole
population of clinical trials in surgery.
General and abdominal surgery comprises a large field
of different operations. Abdominal surgery involves opera-
tions on organs like stomach, liver, pancreas and gut.
Whereas, general surgery involves an inhomogeneous
spectrum of operations, e.g. surgery of the thyroid gland,
hernias and proctology. Surgery is a field with high poten-
tial for innovation because of the constant development of
new interventions, especially with regard to medical de-
vices. Implementation of new interventions is commonly
justified on the basis of clinical trials. Thus, any industry
bias would have a relevant impact on surgical practice.
This protocol describes the methods to perform a system-





Leopold [8] Orthopaedics 3 journals
Ezzet [6] Orthopaedics 3 journals, 2 congresses
Bhandari [5] Different fields of
surgery
8 journals
Shah [13] Orthopaedics 1 journal
Lynch [10] Orthopaedics 1 journal (submitted
manuscripts)
Okike [12] Orthopaedics 2 congresses
Lubowitz [9] Orthopaedics MEDLINE
Yao [15] ORL 4 journals
Khan [7] Orthopaedics 5 journals
Momeni [11] Plastic surgery 3 journals
Sun [14] ORL MEDLINE, EMBASE, CINAHL,
CENTRAL
CCT controlled clinical trial.trials for a primary statistical analysis. The influence of in-
dustry sponsorship in general and abdominal surgery will
be evaluated for the first time.Methods/design
Research question
This study will firstly aim to determine whether there is
an association between industry sponsorship and posi-
tive outcome in randomised controlled trials (RCTs) in
the field of general and abdominal surgery.
Second, methodological differences between industry-
and non-industry-funded RCT will be evaluated in order
to explore potential sources of industry bias.Systematic literature search methodology
One of the major challenges of this study will be the iden-
tification of a representative sample of trials within the
field of general and abdominal surgery that is potentially
at risk for industry bias. Trials without intrinsic commer-
cial interest will have to be excluded from the study sam-
ple (Figure 1). Consequently, trials evaluating surgical
strategies such as the Shouldice vs. Bassini operation for
repair of inguinal hernia will not be investigated as no
commercial interest can be directly related to the efficacy
of the experimental intervention. On the basis of a prelim-
inary literature screening, trials dealing with medical de-









All (n = 301) 79% vs. 64% p = 0.0390
12 months
(2001–2002)
All (n = 173) 86% vs. 24% p < 0.0001
18 months
(1999–2001)
RCT (n = 87) 81% vs. 68% p = 0.4385
19 months
(2002–2003)
All (n = 527) 73% vs. 44% p < 0.0001
17 months
(2004–2005)
All (n = 208) 74% vs. 70% p = 0.7070
2001 + 2002 All (n = 494) 98% vs. 88% p = 0.0258
Open–2005 CCT/RCT (n = 23) 100% vs. 86% p = 0.6637
60 months
(2000–2005)
RCT (n = 202) 81% vs. 79% p = 0.8538
24 months
(2002–2004)
RCT (n = 100) 85% vs. <45% p < 0.0001
15 years
(1990–2005)
CCT/RCT (n = 63) 74% vs. 64% p = 0.5900
1960–2010 RCT (n = 118) 35% vs. 51% p = 0.2067
Figure 1 Conceptual visualisation of existing RCT in surgery,
divided into three major areas: medical devices, drugs/nutrition
and surgical strategy. The grey shading represents the study
sample at risk for industry bias.
Figure 2 Preliminary PICO question and holistic search strategy.
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industry involvement.
A research question was formulated according to the
Participants, Interventions, Comparisons and Outcomes
(PICO) model [16]. Figure 2 shows the preliminary PICO
question with the search strategy. Due to the holistic
approach, this search strategy was very unspecific, with
precision below 3% on the abstract screening. Alteration
of search terms did not improve precision substantially.
However, abstracts identified by the preliminary search
were screened for surgical interventions of interest and
classified into 14 subfields (Figure 3). On this basis, a new
form of comprehensive literature search was developed,
the “multi-PICO search strategy” (MPSS):
– First, the preliminary PICO question served as the
“master PICO”.
– Second, one or more specific questions called
“minor PICOs” were created for every recorded
subfield (e.g. Stapler, Figure 4).
Based on the minor PICOs, a systematic literature
search will be performed independently by two reviewers
Figure 3 On the basis of a preliminary literature screening, subfields with potential industrial background were recorded. Trials from
these subfields will be gathered according to a multi-PICO search strategy.
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oration [16]. The following databases will be searched:
Cochrane Library, MEDLINE (via PubMed) and EMBASE.
A search strategy based on a vocabulary thesaurus
(MeSH or Emtree) in combination with text words will
be used. Additionally, a hand search in relevant cita-
tions will be performed. The search will be limited to
the period from January 1985 to July 2014, with theFigure 4 Minor PICOs for the subfield Stapler.rationale that disclosure of funding source was not
demanded before 1985. No language restrictions will be
applied.
All details of the performed MPSS are displayed in
Additional file 1. Archiving of MPSS followed the same
rules as for a single-PICO search strategy [17].
The method of MPSS allowed the creation of a specific
search for every subfield of investigation.
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Articles gathered by the MPSS will be screened for eligi-
bility according to the following criteria.
Inclusion criteria
RCT assessing the efficacy or effectiveness of medical de-
vices and perioperative pharmacological and nutritional
interventions with direct relation to the surgical proced-
ure in human patient populations in the field of general
and abdominal surgery will be eligible.
Exclusion criteria
RCT without funding information.
RCT assessing neurosurgical, urological, orthopaedic,
dental, plastic, cardiothoracic, gynaecologic, dermal, vas-
cular or paediatric surgery and otorhinolaryngological or
endoscopic interventions.
Thus, a systematic search for surgical RCT in general
and abdominal surgery with potential risk for industry
bias will yield a broad and representative sample to
answer the primary research question.
Data extraction
The full data extraction sheet is displayed in Additional
file 2. Here, only items evaluating the research question
are defined (Table 2).
A trial will be classed as industry funded if any funding is
explicitly stated, regardless of whether the funding took the
form of direct financial support, supply of products for use
in the study or the conduct of trial tasks, e.g. data analysis.
Trials will be dichotomised according to whether the au-
thors conclude the experimental intervention to be superior
to the control intervention. The conclusions drawn by the
authors will be compared to the data presented. A conclu-




Experimental intervention is reported
to be superior to the control intervention
[Yes/no]
Exact p value of the primary endpoint [n]
Year of publication [n]
Impact factor of journal [n]
Region [National/
multinational]
Number of study centres [n]
Sample size [n]
Concluded superiority without statistical
significance of primary endpoint
[Yes/no]
Risk of bias for primary endpoint according to
Cochrane Collaboration’s tool for assessing risk of
bias
[Low/high/
unclear]non-significant differences between groups will be recorded.
Risk of bias will be assessed according to the Cochrane
Collaboration’s tool for assessing risk of bias [16]. Further
study characteristics will be captured for multivariate ana-
lysis as stated in the “Statistical analysis” section below.
Data extraction will be performed by two reviewers in-
dependently for quality assurance purposes [18]. Discrep-
ancies between the two reviewers will be resolved by a
third reviewer, and a final extraction sheet will be deter-
mined for database entry. A database monitoring will be
performed of 100% of data necessary to evaluate the pri-
mary endpoint and a randomly selected 20% of remaining
data. Finally, the database will be closed and made avail-
able for statistical analysis.Statistical analysis
A primary statistical analysis will be performed to answer
the primary research question regarding the association of
industry sponsorship and positive outcome as well as the
magnitude of this association. Therefore, trials will be di-
vided into those funded by industry and those not funded
by industry. Further, trials will be dichotomised according to
whether or not the experimental intervention is reported to
be superior to the control group. The chance that industry-
funded trials report more positive outcomes is expressed as
odds ratio (OR). The null hypothesis (H0) is that industry
funding is not associated with a positive trial outcome. The
alternative hypothesis (H1) is that industry funding is associ-
ated with a positive trial outcome. The significance of asso-
ciation will be tested by means of Fisher’s exact test if at
least one value in the contingency table is 5 or below.
Pearson’s chi-squared test with Yates’s correction will be
used if the total sample size is 60 or less. In all other cases,
significance of association will be tested using Pearson’s
chi-squared test without Yates’s correction at a level of
significance of 5%. Furthermore, a multivariate logistic
regression with factors (multinational trials, methodo-
logical quality) and covariates (number of study centres,
journal impact factor, sample size) will be conducted. An
additional analysis will be performed for the three
subgroups medical devices, pharmaceuticals and nutrition.
Moreover, by comparison of reported p values of
primary endpoints from industry-funded and independ-
ently funded trials, a possible industry bias will be quanti-
fied. Student’s t-test or the Wilcoxon rank-sum test will be
used for exact p values. If 20% of p values are not reported
exactly, the p values will be classified and Fisher’s exact
test or a chi-squared test will be performed.
Additional data extracted will be presented descriptively.
Publication bias will be explored using a funnel plot
separately for industry-sponsored trials and non-industry-
sponsored trials. Statistical analysis will be performed with
R [19].
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Existing literature about association of industry sponsor-
ship and positive outcome in surgery has major limitations
due to the approach to primary trials as mentioned above.
Therefore, the presence and extent of such association in
randomised controlled trials in general and abdominal
surgery remains unexplored.
In the case of the hypothesised association of industry
sponsorship and positive outcome, this study will inves-
tigate by a multivariate statistical analysis whether indus-
try involvement biases result via standard risk domains
or if industry involvement is an independent source of
bias as assumed by several studies [4,20].
The conduct of this study is important, because the
detection of an industry bias in surgery would have an
impact on future research. The findings of this study will
enable surgical societies, in particular, to give advice about
cooperation with industry and disclosure of funding
source based on empirical evidence.
Additional files
Additional file 1: Detailed MPSS. Detailed information on the
multi-PICO search strategy including search terms for MEDLINE.
Additional file 2: Extraction sheet. Standardised data collection form
that will be used to extract data from included studies.
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